| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2103251 | Biology of Blood and Marrow Transplantation | 2011 | 6 Pages |
Abstract
Infection because of herpes simplex virus (HSV) that is resistant to acyclovir (ACV) poses treatment challenges in hematopoietic cell transplant (HCT) patients. We present a series of patients with ACV-resistant HSV following HCT who were successfully treated with continuous infusion high-dose ACV after failing standard treatment regimens for ACV-resistant HSV.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Janet H. Kim, Joanna M. Schaenman, Dora Y. Ho, Janice M.Y. Brown,